N-Acetyl-Cysteine (NAC) in Early Phase Schizophrenia Spectrum Psychosis (NACPSY)

This study has been completed.
Sponsor:
Collaborator:
Center de Neurosciences Psychiatrique, Lausanne, Switzerland
Information provided by (Responsible Party):
Tsung-Ung Wilson Woo, Beth Israel Deaconess Medical Center
ClinicalTrials.gov Identifier:
NCT01354132
First received: May 13, 2011
Last updated: May 26, 2015
Last verified: May 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2014
  Primary Completion Date: August 2014 (Final data collection date for primary outcome measure)